These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31012948)

  • 41. Sex dimorphism in the onset of the white adipose tissue insulin sensitivity impairment associated with age.
    Amengual-Cladera E; Lladó I; Proenza AM; Gianotti M
    Biochimie; 2014 Nov; 106():75-80. PubMed ID: 25128631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism.
    Landrier JF; Gouranton E; El Yazidi C; Malezet C; Balaguer P; Borel P; Amiot MJ
    Endocrinology; 2009 Dec; 150(12):5318-25. PubMed ID: 19833717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
    Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
    Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice.
    Bak EJ; Kim J; Choi YH; Kim JH; Lee DE; Woo GH; Cha JH; Yoo YJ
    Clin Nutr; 2014 Feb; 33(1):156-63. PubMed ID: 23623334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
    Smith AJ; McKernan RM
    Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.
    Antonelli T; Tomasini MC; Mazza R; Fuxe K; Gaetani S; Cuomo V; Tanganelli S; Ferraro L
    J Pharmacol Exp Ther; 2009 May; 329(2):708-17. PubMed ID: 19197005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Egg white hydrolysate shows insulin mimetic and sensitizing effects in 3T3-F442A pre-adipocytes.
    Jahandideh F; Chakrabarti S; Davidge ST; Wu J
    PLoS One; 2017; 12(10):e0185653. PubMed ID: 28972997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.
    Wen D; An M; Gou H; Liu X; Liu L; Ma C; Cong B
    Neurotoxicology; 2016 Dec; 57():31-38. PubMed ID: 27565679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ZBTB16 Overexpression Enhances White Adipogenesis and Induces Brown-Like Adipocyte Formation of Bovine White Intramuscular Preadipocytes.
    Wei S; Zhang M; Zheng Y; Yan P
    Cell Physiol Biochem; 2018; 48(6):2528-2538. PubMed ID: 30121655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.
    Bellier B; Crété D; Million ME; Beslot F; Bado A; Garbay C; Daugé V
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):404-13. PubMed ID: 15480577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
    Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: a fluorescence study on type B receptor fragment CCK(B)-R (352-379).
    De Luca S; Sanseverino M; Zocchi I; Pedone C; Morelli G; Ragone R
    Biopolymers; 2005 Mar; 77(4):205-11. PubMed ID: 15666329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes.
    Zilleßen P; Celner J; Kretschmann A; Pfeifer A; Racké K; Mayer P
    Sci Rep; 2016 Mar; 6():23074. PubMed ID: 26983599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue.
    Bueno AA; Oyama LM; de Oliveira C; Pisani LP; Ribeiro EB; Silveira VL; Oller do Nascimento CM
    Pflugers Arch; 2008 Jan; 455(4):701-9. PubMed ID: 17717684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postsynaptic Depolarization Enhances GABA Drive to Dorsomedial Hypothalamic Neurons through Somatodendritic Cholecystokinin Release.
    Crosby KM; Baimoukhametova DV; Bains JS; Pittman QJ
    J Neurosci; 2015 Sep; 35(38):13160-70. PubMed ID: 26400945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
    Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Very low levels of cholecystokinin octapeptide activate Na-pump in the cerebral cortex of CCK2 receptor-deficient mice.
    Roots K; Kairane C; Salum T; Kõks S; Karelson E; Vasar E; Zilmer M
    Int J Dev Neurosci; 2006 Oct; 24(6):395-400. PubMed ID: 16822640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.